|
⚲
|
| Keyboard |
| Mark Hackett | |
|---|---|
| Firm | Solas BioVentures Management LLC |
| Address | 412 Georgia Ave Suite 201 Chattanooga, TN 37403 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Solas BioVentures Management LLC | |||||
| Solas Basking Holdings | 021-520116 | Executive Officer | 9.0 M | 9.0 M | |
| Solas BioVentures Emerging Healthcare Fund LP | 021-463813 | Executive Officer | 35.1 M | 48.6 M | |
| Solas BioVentures Fund II LP | 021-369247 | Executive Officer | 35.1 M | 28.7 M | |
| Solas Cryosa Sidecar | 021-520120 | Executive Officer | 6.9 M | 3.5 M | |
| Solas Francis Sidecar | 021-520117 | Executive Officer | 9.0 M | 31.0 M | |
| Solas Intershunt Sidecar | 021-535461 | Executive Officer | 1.4 M | 1.5 M | |
| Solas Stimdia Sidecar | 021-520113 | Executive Officer | 7.5 M | 5.3 M | |
| Solas Tvardi Sidecar | 021-535456 | Executive Officer | 13.3 M | 0.6 M | |
| Solas Vesalio Sidecar | 021-520123 | Executive Officer | 5.6 M | 12.0 M | |
| AFTX Inc | 021-338477 | Director | 1.4 M of 2.0 M |
||
| Cardionxt Inc | 021-335841 | Director | 3.0 M of 4.0 M |
||
| Rediscovery Life Sciences AKI LLC | 021-268430 | Director | 0.8 M of 1.5 M |
||
| Glenveigh Pharmaceuticals LLC | 021-178203 | Director | 1.1 M of 1.8 M |
||
| Glenveigh Pharmaceuticals LLC | 021-169367 | Director | 0.2 M of 2.5 M |
||